HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical evaluation of cefodizime in children].

Abstract
Cefodizime (THR-221, CDZM), a new parenteral cephalosporin, was evaluated for its efficacy and safety in 20 children with bacterial infections (Table 1), and the following results were obtained. 1. CDZM was administered in 3 or 4 divided doses at daily dosages ranging from 54.5 to 84.2 mg/kg administered by 30 minutes drip infusion or intravenous injection to 20 patients (7 cases of acute tonsillitis, 6 cases of pneumonia, 2 cases each of bronchitis and suppurative cervical lymphadenitis, and 1 case each of acute pharyngitis, acute enteritis and furunculosis) and the following clinical results were obtained: excellent, 7 cases; good, 11 cases; fair, 2 cases. The overall efficacy rate was 90% (Table 4). 2. MICs of CDZM against 15 strains of isolated organisms are shown in Table 2. MICs against all 7 strains of Haemophilus influenzae were less than 0.025 micrograms/ml. MIC against 1 out of 5 strains of Streptococcus pneumoniae was 0.05 micrograms/ml and those against 2 strains were 0.10 micrograms/ml and against the other 2 were 0.20 micrograms/ml. MICs against 3 strains of Staphylococcus aureus were 1.56, 25 and higher than 100 micrograms/ml, respectively. 3. No clinical adverse reaction was observed in any of the 20 patients. Eosinophilia was observed in 2 cases. A slight elevation of S-GOT was found in 1 patient (case No. 8) and moderate elevation of S-GOT and S-GPT in another (case No. 18) (Table 4). In case No. 18, the S-GOT and S-GPT activity improved after the administration of the drug was stopped.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsY Mochizuki, D Hata, H Ohkubo, A Yoshida, H Uenoyama, H Tsuda, H Nakato, M Mayumi, H Mikawa
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 42 Issue 6 Pg. 1358-65 (Jun 1989) ISSN: 0368-2781 [Print] Japan
PMID2795859 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Cefotaxime
  • cefodizime
Topics
  • Age Factors
  • Bacteria (drug effects, isolation & purification)
  • Bacterial Infections (drug therapy, microbiology)
  • Cefotaxime (adverse effects, analogs & derivatives, pharmacology, therapeutic use)
  • Child
  • Child, Preschool
  • Drug Evaluation
  • Drug Resistance, Microbial
  • Female
  • Humans
  • Infant
  • Male
  • Pneumonia (drug therapy)
  • Tonsillitis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: